NR1H3 and atherosclerosis: Besides the above biological effects, our previous study has shown that ginsenoside compound K could attenuate the formation of atherosclerosis in mice via activating LXRα [12], without presentation of the serious side effects caused by synthetic unspecific LXRs agonists, such as the elevation of plasma triglycerides [13] and liver steatosis [14].